Eli Lilly and CompanyEli Lilly and Company Facebook ad: “GLP-1 pill shows cardiovascular safety”
Ran for 18 days, from April 17 to May 5, 2026, the last day Crush saw it.
Run by Eli Lilly and Company on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 839546559164704
- Platforms
- Relaunches
- 0
Ad text
In a late-stage study in type 2 diabetes and elevated cardiovascular risk, our new GLP-1 pill showed cardiovascular safety.
Where the ad sends people
investor.lilly.com
GLP-1 pill shows cardiovascular safety
Learn more: e.lilly(opens in a new tab)
